In analyses where all women were included, a negative VDR expression was associated with a relatively higher breast cancer mortality in the crude (HR: 2.08, 95% CI: 1.30–3.32) and the adjusted (HR: 1.62, 95% CI: 0.99–2.65) analyses, although adjustments attenuated the results. Here, VDR is linked to breast carcinoma.